Looking to snag some hardware and gaming tech during this year's Amazon Prime Days? We've got our favorite picks in one easy ...

MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The ...